GeoVax Financial Statements From 2010 to 2026

GOVX Stock  USD 2.73  0.09  3.19%   
GeoVax Labs' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing GeoVax Labs' valuation are provided below:
Gross Profit
-19.4 M
Market Capitalization
4.6 M
Enterprise Value Revenue
0.9352
Revenue
3.4 M
Earnings Share
(31.75)
We have found one hundred twenty available fundamental trends for GeoVax Labs, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of GeoVax Labs regular market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 14 M in 2026. Enterprise Value is likely to drop to about 8 M in 2026

GeoVax Labs Total Revenue

3.74 Million

Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 81.5 K, Interest Expense of 18.3 K or Total Revenue of 3.7 M, as well as many indicators such as Price To Sales Ratio of 3.54, Dividend Yield of 0.0 or PTB Ratio of 2.77. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.
  
Build AI portfolio with GeoVax Stock
Check out the analysis of GeoVax Labs Correlation against competitors.
For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

GeoVax Labs Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.1 M9.4 M5.9 M
Slightly volatile
Short and Long Term Debt Total169.3 K178.3 K209.8 K
Pretty Stable
Other Current Liabilities1.5 M1.4 MM
Slightly volatile
Total Current Liabilities1.9 M3.6 M1.8 M
Slightly volatile
Property Plant And Equipment Net128.2 K135 K245.4 K
Pretty Stable
Accounts Payable2.2 M2.1 M843.4 K
Slightly volatile
Cash3.4 M6.3 M4.7 M
Slightly volatile
Non Current Assets Total188.9 K198.9 K336.1 K
Slightly volatile
Cash And Short Term Investments3.4 M6.3 M4.7 M
Slightly volatile
Net Receivables623.1 K593.5 K264.5 K
Slightly volatile
Common Stock Shares Outstanding6.3 MM1.2 M
Slightly volatile
Liabilities And Stockholders Equity5.1 M9.4 M5.9 M
Slightly volatile
Other Current Assets2.9 T2.8 T479.5 B
Slightly volatile
Other Stockholder Equity162.3 T154.6 T26.5 T
Slightly volatile
Total Liabilities2.1 M3.6 M1.9 M
Slightly volatile
Total Current Assets9.6 M9.1 M5.8 M
Slightly volatile
Common StockK9.5 K35.5 K
Pretty Stable
Good Will6.1 M5.9 M4.9 M
Slightly volatile
Short Term Debt156.7 K165 K206.2 K
Slightly volatile
Non Currrent Assets Other12 K12.7 K218 K
Slightly volatile
Other Assets2.6 M2.5 M736.6 K
Slightly volatile
Long Term Debt12.6 K13.3 K32.1 K
Slightly volatile
Intangible Assets51.3 K54 K359.5 K
Slightly volatile
Property Plant Equipment229.1 K211.4 K212.7 K
Slightly volatile
Current Deferred Revenue290.7 K368.7 K308.9 K
Slightly volatile
Common Stock Total Equity3.3 K3.5 K36.1 K
Slightly volatile
Preferred Stock Total Equity83.1 K87.5 K399.7 K
Slightly volatile
Property Plant And Equipment Gross1.1 MM378.7 K
Slightly volatile
Short and Long Term Debt121.7 K165 K209.4 K
Slightly volatile
Capital StockK9.5 K1.3 M
Slightly volatile
Capital Surpluse44.2 M49.8 M54.3 M
Slightly volatile
Other Liabilities1.6 M1.8 MM
Slightly volatile
Non Current Liabilities Other1.6 M1.8 MM
Slightly volatile
Short Term Investments4.4 TT5.4 T
Slightly volatile

GeoVax Labs Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization81.5 K85.8 K55.8 K
Very volatile
Other Operating Expenses35.1 M33.5 M11.9 M
Slightly volatile
Research Development28.6 M27.3 M8.8 M
Slightly volatile
Cost Of Revenue104.2 K109.7 K3.8 M
Very volatile
Total Operating Expenses35 M33.4 M10.6 M
Slightly volatile
Selling General Administrative4.6 M4.8 M177.8 M
Slightly volatile
Interest Income108 K199.4 K70.7 K
Slightly volatile
Reconciled Depreciation115.2 K109.7 K44.3 K
Slightly volatile
Non Operating Income Net Other1.8 KK2.2 K
Slightly volatile

GeoVax Labs Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow7.8 M7.4 M4.7 M
Slightly volatile
Depreciation81.5 K85.8 K55.8 K
Very volatile
Total Cash From Financing Activities28.7 M27.3 M9.5 M
Slightly volatile
End Period Cash Flow3.4 M6.3 M4.7 M
Slightly volatile
Stock Based Compensation511.2 K475.8 K576.5 K
Pretty Stable
Change To Netincome1.1 MM564.2 K
Slightly volatile
Cash And Cash Equivalents Changes7.7 M8.6 M9.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.543.731.2 B
Slightly volatile
Days Sales Outstanding11969.9945.2273
Slightly volatile
Average Payables413.4 K241.7 K300.6 K
Slightly volatile
Stock Based Compensation To Revenue0.110.120.9635
Pretty Stable
Capex To Depreciation0.190.216633.6093
Pretty Stable
Payables Turnover0.04410.046411.8828
Slightly volatile
Sales General And Administrative To Revenue1.491.5741.0993
Slightly volatile
Average Inventory559.5 K588.9 K612.3 K
Slightly volatile
Research And Ddevelopement To Revenue6.425.411.4876
Slightly volatile
Capex To Revenue0.00450.00471.2959
Pretty Stable
Cash Per Share23.8223.8941.396
Slightly volatile
Days Payables Outstanding6.7 K6.4 K1.2 K
Slightly volatile
Income Quality0.610.890.7995
Pretty Stable
Intangibles To Total Assets0.0080.00850.0125
Slightly volatile
Current Ratio4.722.944.6364
Slightly volatile
Receivables Turnover6.556.913.9488
Slightly volatile
Capex Per Share0.08510.08969.613
Pretty Stable
Average Receivables248.6 K379.2 K195 K
Slightly volatile
Revenue Per Share20.1521.9214.973
Pretty Stable
Interest Debt Per Share0.110.121.5305
Slightly volatile
Debt To Assets0.02080.02190.1579
Slightly volatile
Graham Number398448488
Slightly volatile
Operating Cycle66.4969.99245
Slightly volatile
Days Of Payables Outstanding6.7 K6.4 K1.2 K
Slightly volatile
Ebt Per Ebit1.091.1459.7282
Slightly volatile
Quick Ratio3.022.33.9188
Pretty Stable
Cash Ratio2.621.63.4122
Very volatile
Days Of Sales Outstanding11969.9945.2273
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.140.91.5001
Pretty Stable
Fixed Asset Turnover13.5923.7323.3554
Very volatile
Debt Ratio0.02080.02190.1579
Slightly volatile
Price Sales Ratio3.543.731.2 B
Slightly volatile
Asset Turnover0.720.440.9729
Slightly volatile

GeoVax Labs Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap14 M14.7 M289.1 M
Slightly volatile

GeoVax Fundamental Market Drivers

Forward Price Earnings10.627
Cash And Short Term Investments5.5 M

GeoVax Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue368.7 K290.7 K
Total Revenue3.6 M3.7 M
Cost Of Revenue109.7 K104.2 K
Stock Based Compensation To Revenue 0.12  0.11 
Sales General And Administrative To Revenue 1.57  1.49 
Research And Ddevelopement To Revenue 5.40  6.42 
Revenue Per Share 21.92  20.15 
Ebit Per Revenue(7.31)(7.68)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.